Akihiro Tanaka

Pharmacological Profile of YM087, A Novel Potent Nonpeptide Vasopressin V1A and V2 Receptor Antagonist, in Vitro and in Vivo

Atsuo Tahara, Yuichi Tomura, Koh‐ichi Wada et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 140 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Association Between Immune-Related Adverse Events and Clinical Efficacy in Patients with Melanoma Treated With Nivolumab: A Multicenter Retrospective Study

Naoto Okada, Kenshi Takechi, Yoshihiro Matsudate et al. · Clinical Therapeutics · 2018 · 99 citations

Medicine, Immunology, Oncology +17

Pharmacological profile of YM087, a novel nonpeptide dual vasopressin V1A and V2 receptor antagonist, in dogs

Takeyuki Yatsu, Yuichi Tomura, Atsuo Tahara et al. · European Journal of Pharmacology · 1997 · 78 citations

Medicine, Pharmacology, Veterinary Pharmacology +8

Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced protein synthesis in neonatal rat cardiomyocyte

Atsuo Tahara, Yuichi Tomura, Koh‐ichi Wada et al. · Cardiovascular Research · 1998 · 71 citations · Full text

Life Sciences, Cardiology, Pharmacology +14

Population Pharmacokinetic Analysis of Vancomycin Using Serum Cystatin C as a Marker of Renal Function

Akihiro Tanaka, Tetsuya Aiba, Takashi Otsuka et al. · Antimicrobial Agents and Chemotherapy · 2009 · 64 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17